- Advance Directive Policy (CO291)
- Authorization and Certification (UM203)
- Delegated Vendor Oversight Policy (CO321)
- Emergency Fill Policy (PM516)
- Exclusion Screening Policy (CO318)
- Extension of Benefit Limitations (UM428)
- Filing Forms B, C, and D with the Office of the Insurance Commissioner (OIC) (CO362)
- Hospice Care, Pediatric Concurrent Care, and Pediatric Palliative Care Policy (MM163)
- Hospital Admission Patient Management (UM211)
- Injectable Medications Policy (PM566)
- Involuntary Disenrollment Policy (EM111)
- Medicare Opioid Overutilization Program Policy (PM564)
- Patient Review and Coordination Program Policy (PM563)
- Pharmaceutical Management Procedures Policy (PM508)
- Pharmaceutical Patient Safety Policy (PM509)
- Pharmacy Access During a Federal Disaster or Other Public Health Emergency Declaration Policy (PM514)
- Pharmacy Review of Coverage Redeterminations (PM555)
- PCP Assignment (CS437)
- PCP Assignments for State Programs (EL150)
- Prescription Claim Processing for Part D Policy (PM558)
- Prohibition on Enrollee Charges for Covered Services (PR153)
- Provider Data for Directories (PD104)
- Quantity Limits Policy (PM506)
- Reporting Requirements for Medicare Part D Policy (PM561)
- Security Incident Response Policy (CO370)
- Step Therapy Policy (PM507)
- Transition Process Policy - MA (PM553)
- Transition Process Policy (PM515)
- Nurse Advice Line 1-866-418-2920
TTY: Dial 7-1-1